The analyst who spent four years on the sidelines now sees real progress in Intel's chipmaking and design. Here's what it means for the turnaround story.

A Russian military spacecraft closed from hundreds of kilometers to extreme proximity with a commercial satellite, signaling a new orbital threat to private assets.

All-cash acquisition delivers divesiran, a late-stage-ready experimental treatment, to Merck KGaA's pipeline.

An LA restaurant group's Kalshi trade paid off when the Dodgers lost, and small businesses are flocking to prediction markets to hedge everything from playoff runs to cold fronts.

The journalist who exposed Theranos says the Oscar-buzzed film is art, not evidence, and the distinction matters for anyone weighing a founder's story.

Expanding its X-energy deal, Amazon funds 12 unproven SMRs for Indiana, but no US small reactor is operating and the mid-2030s timeline is far from locked.

A federal judge ordered Abdulrahman Alfozan held without bail after prosecutors detailed WhatsApp chats with Saudi royalty and a military-booked flight for his family.

The Tel Aviv startup's code execution model formally verifies optimizations, turning AI into an agent for the hardware itself.

MIT team traces APOE4's damage to lipid droplets, opening a new drug target beyond amyloid and tau.

Amazon, Yelp, and Pizza Hut are blocking OpenAI's and Meta's new shopping agents, and a web optimized for bots could squeeze out the humans who built it.

The federal ban on the low-cost Chinese model signals a new front in AI supply-chain security, with compliance and vendor implications.

The Vietnamese automaker's asset sale raises fresh questions about its cash runway and the true cost of its EV push.